MMTZFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as RLFTY
MindMaze Therapeutics Holding SA
Financials through fiscal 2023, year ended Dec 31, 2023Last filing: 20-F on Apr 30, 2024
$0.19−0.00 (-0.22%)
Close on Oct 19, 2026
Debt
Borrowings on the balance sheet, Dec 31, 2023
Total debt
CHF 346.00K
CHF 337.00K due within a year
Net debt
-CHF 14.21M
After CHF 14.56M of cash
Implied interest rate
258.58%
FY2023 interest ÷ average debt
Interest coverage
-116.8×
FY2023 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, CHF
Bond issues
Individual notes and bonds outstanding
Bond-level data is not connected yet
Coupon, maturity and amount of each note will come from the debt footnote in MindMaze Therapeutics's annual report. Trading prices and yields need FINRA TRACE data.